REFERENCES
- Dobbie JW. Pathogenesis of peritoneal fibrosis (scleros-ing peritonitis) in peritoneal dialysis. Petit Dial Int 1992; 12: 14–27.
- Davies SJ, Bryan J, Phillips L, Russel GI. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498–506.
- Beavis MJ, Williams JD, Hoppe J, Topley N. Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kidney Int 1997; 51: 205–15.
- Yung S, Coles GA, Davies M. IL-1fl, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. Kidney Int 1996; 50: 1337–43.
- Breborowicz A, Wisnievska J, Polubinska A, Wieczor-owska-Tobis K, Martis L, Oreopoulos DG. Role of peritoneal mesothelial cells and . broblasts in the synthesis of hyaluronan during peritoneal dialysis. Perit Dial Int 1998; 18: 382�6.
- Mateijsen MAM, van der Wal AC, Hendriks PEME, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517�25.
- Tanaka Y, Katoh S, Hori S, Miura M, Yamashita H. Vascular endothelial growth factor in diabetic retinopathy. Lancet 1997; 349: 1520.
- Haraldsson B. Assessing the peritoneal dialysis capa-cities of individual patients. Kidney Int 1995; 47: 1187–98.
- Teppo A-M, Metsa�rinne K, Fyhrquist F. Radioimmunoassay of interleukin-6 in plasma. Clin Chem 1991; 37: 1691�5.
- Teppo A-M, Maury CPJ. Radioimmunoassay of tumor necrosis factor-a in serum. Clin Chem 1987; 33: 2024–7.
- Vesaluoma M, Teppo A-M, Grönhagen-Riska C, Tervo T. Release of TGF-fll and VEGF in tears following photoreactive keratectomy. Curr Eye Res 1997; 16: 19–25.
- Wu GG, Oreopoulos DG. Assessing peritoneal ultrafil-tration and solute transport. In: Daugirdas JT, Ing TS, eds. Handbook of dialysis, 2nd edn. New York: Little, Brown and Company, 1994: 328–37.
- Gallard R, Gearing A. The cytokine facts book. New York: Academic Press, 1994: 64–9.
- Van der Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13–33.
- Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3588–93.
- Teppo A-M, von Willebrand E, Honkanen E, Ahonen J, Grönhagen-Riska C. Soluble intercellular adhesion mol-ecule-1 (5ICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1? Transplantation 2001; 71: 1113–9.
- Laurent TC, Fraser IRE. Hyaluronan. FASEB J 1992; 6: 2397–404.
- Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986; 119: 219–34.
- Yamagata K, Tomida C, Koyama A. Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients. Petit Dial Int 1999; 19: 131–7.
- Lin C-Y, Chen W-P, Fu L-W, Yang L-Y, Huang T-P. Persistent transforming growth factor fil expression may predict peritoneal fibrosis in CAPD patients with recurrent peritonitis occurrence. Adv Petit Dial 1997; 13: 64–71.
- Yung S, Coles GA, Williams JD, Davies M. The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 1994; 46: 527–33.